Meta-analysis of the addition of docetaxel to ADT in hormone-sensitive metastatic prostate cancer
By Matteo Stenger Posted: 14/07/2023 10:57:00 Last update: 07/14/2023 12:02:42 In a systematic review and single patient meta-analysis reported in The Oncological Lancet, Claire L. Vale, PhDand colleagues from the STOPCAP M1 collaboration identified factors associated and unassociated with improved outcomes after the addition of docetaxel to androgen deprivation therapy (ADT) in hormone-responsive metastatic prostate … Read more